Context Therapeutics Inc. (CNTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of CNTX. The 7-day demo opens the 1M and 3M ranges and puts CNTX on your watchlist.
Start 7-day demoLatest CNTX insider trades
Andy Pasternak - DirectorGrant or award45,000 sh- Jennifer Evans Stacey - DirectorGrant or award45,000 sh
- Linda West - Director
About Context Therapeutics Inc. (CNTX)
The SEC lists Context Therapeutics Inc. under CIK 0001842952, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
CNTX Form 4 activity by transaction type, last 90 days
No Form 4 activity for CNTX in the last 90 days.
CNTX insider transactions (Form 4)
1010 Form 4 filings on record, the earliest from Feb 23, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Andy Pasternak - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Jennifer Evans Stacey - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Linda West - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Karen L. Smith - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Luke Nathaniel Walker - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
 Philip W. Kantoff - Director | Grant or award | Stock Option (right to buy) | 45,000 | $0.00 | - | |
 Alex C. Levit - Officer | Grant or award | Stock Option (right to buy) | 270,000 | $0.00 | - | |
| Jennifer Lynn Minai-Azary - Officer | Grant or award | Stock Option (right to buy) | 275,000 | $0.00 | - | |
 Karen Deborah Chagin - Officer | Grant or award | Stock Option (right to buy) | 290,000 | $0.00 | - | |
 Martin A. Lehr - Officer | Grant or award | Stock Option (right to buy) | 815,000 | $0.00 | - |
CNTX insider trading FAQ
What is the latest insider trade for CNTX?
Context Therapeutics Inc. (CNTX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-26. The full record for CNTX runs to 10 Form 4 filings, the earliest from 2026-02-23. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CNTX stock?
No insider purchases of CNTX were filed in the last 90 days.
How many insiders are selling CNTX stock?
No insider sales of CNTX were filed in the last 90 days.
Where can I see CNTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CNTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andy Pasternak view on EDGAR
- - Jennifer Evans Stacey view on EDGAR
- - Linda West view on EDGAR
- - Karen L. Smith view on EDGAR
- - Luke Nathaniel Walker view on EDGAR
- - Philip W. Kantoff view on EDGAR
- - Alex C. Levit view on EDGAR
- - Jennifer Lynn Minai-Azary view on EDGAR
- - Karen Deborah Chagin view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CNTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CNTX with a 7-day demo
- CNTX on your watchlist
- Every CNTX Form 4 filing on record
- Up to 3 months of CNTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
